Evaluation of the Relationship between Prostate Cancer and Serum İnflammation Markers

In this study, we aimed to examine whether there is a relationship between the serum inflammation markers C-Reactive Protein (CRP), Lactate Dehydrogenase (LDH), erythrocyte sedimantation rate (ESR), ceruloplasmin; and stage of prostate cancer (Pca), serum prostate specific antigen (PSA) level and Gleason score in prostate cancer(Pca) patients.

6, and further the cases with and without bone metastasis.

20 ng/mL, compared with the ones with serum PSA levels≤20 ng/mL in the Pca group, as well (p<0.05).

As a result, it is determined that, the serum inflammation markers are significantly higher at the patients with prostate cancer, especially for the ones with higher PSA and Gleason score.